Início › Câncer Metastático › Califórnia › Mountain View
Ensaios clínicos de Câncer Metastático em Mountain View, CA
25 estudos para Câncer Metastático estão buscando participantes em locais em Mountain View e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · a 5 mi de distância
- VA Palo Alto Health Care System, Palo Alto · a 5 mi de distância
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RecrutandoFase 1/2
- Stanford, Palo Alto · a 5 mi de distância
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecrutandoFase 2/3
- Stanford Cancer Center, Palo Alto · a 5 mi de distância
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecrutandoFase 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · a 5 mi de distância
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
RecrutandoFase 1/2
- Stanford Medicine, Palo Alto · a 5 mi de distância
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
RecrutandoFase 1
- Stanford Cancer Institute, Stanford · a 5 mi de distância
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecrutandoFase 1
- Stanford University Medical Center, Stanford · a 5 mi de distância
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecrutandoFase 3
- Stanford Women's Cancer Center, Palo Alto · a 5 mi de distância
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecrutandoFase 3
- Stanford Cancer Center, Palo Alto · a 5 mi de distância
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- Stanford Cancer Institute, Stanford · a 5 mi de distância
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
RecrutandoFase 2
- Stanford University, Palo Alto · a 5 mi de distância
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RecrutandoFase 3
- Research Site, Palo Alto · a 5 mi de distância
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
RecrutandoFase 1/2
- Stanford Cancer Institute (SCI), Stanford · a 5 mi de distância
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecrutandoFase 1
- Stanford Medicine Cancer Center, Stanford · a 5 mi de distância
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · a 5 mi de distância
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
RecrutandoFase 3
- Stanford University School of Medicine, Palo Alto · a 5 mi de distância
A Study of LY4175408 in Participants With Advanced Cancer
RecrutandoFase 1
- Stanford Medicine Cancer Center, Stanford · a 5 mi de distância
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RecrutandoFase 1/2
- Stanford Cancer Institute, Stanford · a 5 mi de distância
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RecrutandoFase 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · a 5 mi de distância
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecrutandoFase 2/3
- Stanford Cancer Institute, Palo Alto · a 5 mi de distância
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RecrutandoFase 1
- Stanford Cancer Institute, Stanford · a 5 mi de distância
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
RecrutandoFase 1
- Stanford Cancer Institute, Stanford · a 5 mi de distância
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
RecrutandoEstudo observacional
- VA Palo Alto Healthcare System, Palo Alto · a 5 mi de distância
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RecrutandoFase 1
- Stanford Cancer Institute, Palo Alto · a 5 mi de distância
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Stanford · a 5 mi de distância
Ensaios de Câncer Metastático em outras cidades
- Houston, TX104 estudos
- New York City, NY93 estudos
- Nashville, TN70 estudos
- Boston, MA63 estudos
- Los Angeles, CA57 estudos
- St. Louis, MO54 estudos
- Arlington, VA53 estudos
- Philadelphia, PA46 estudos
- Chicago, IL45 estudos
- San Antonio, TX44 estudos
- Washington, DC43 estudos
- Dallas, TX42 estudos
Outros estudos em Mountain View
- Câncer (todos os tipos)40 estudos
- Câncer de Mama26 estudos
- Câncer de Pulmão de Não Pequenas Células21 estudos
- Leucemia Mieloide Aguda19 estudos
- Câncer de Ovário19 estudos
- Transtorno do Espectro Autista17 estudos
- Câncer de Pulmão17 estudos
- Câncer de Próstata15 estudos
- Insuficiência Cardíaca15 estudos
- Autismo13 estudos
- Leucemia Linfoblástica Aguda13 estudos
- Câncer Colorretal13 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.